AR and prostate cancer: By luciferase reporter assays and ChIP analyses, the miR-1-2 promoter region was shown to be activated by the AR, and miR-1 targeting ‘tyrosine-protein kinase’ (SRC) in DU145 derived prostate cancer cell lines [94].